The rising prevalence in GLP-1 agonists for diabetes has led to a discussion about delivery methods : skin-applied devices versus pills . Typically, GLP-1 drugs were solely available in pill form, but the https://adamcuhs222883.jiliblog.com/97344255/glp-1-transdermal-delivery-systems-vs-oral-medications-what-best-for-individuals